Cargando…
Corrigendum: Revisiting Stem Cell-Based Clinical Trials for Ischemic Stroke
Autores principales: | He, Joy Q., Sussman, Eric S., Steinberg, Gary K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961504/ https://www.ncbi.nlm.nih.gov/pubmed/35360207 http://dx.doi.org/10.3389/fnagi.2022.875925 |
Ejemplares similares
-
Revisiting Stem Cell-Based Clinical Trials for Ischemic Stroke
por: He, Joy Q., et al.
Publicado: (2020) -
Corrigendum: Systemic-immune-inflammation index as a promising biomarker for predicting perioperative ischemic stroke in older patients who underwent non-cardiac surgery
por: Zhang, Faqiang, et al.
Publicado: (2022) -
Is Immune Suppression Involved in the Ischemic Stroke? A Study Based on Computational Biology
por: Wang, Xin, et al.
Publicado: (2022) -
Eosinophils, Stroke-Associated Pneumonia, and Outcome After Mechanical Thrombectomy for Acute Ischemic Stroke
por: Guo, Zhiliang, et al.
Publicado: (2022) -
Corrigendum: Type 2 diabetes increases risk of unfavorable survival outcome for postoperative ischemic stroke in patients who underwent non-cardiac surgery: A retrospective cohort study
por: Zhang, Faqiang, et al.
Publicado: (2023)